Work

Behind Stem-Cell Rules’ Heed and Re-Open for Trials in China

Year: 2017
Type: article
Abstract: Applaud China for launching trials of embryonic stem cells.Studies to treat vision loss and Parkinson's disease are the pilot to go ahead under new regulations.1 Almost 5 years ago, 'China's stem-cell rules go unheeded' 2 has been raised for stem cell therapy (SCT) in China.However, it has neglected that such rules' heed is inextricable from China cultural and tradition contexts.For our society, China has tri-systems (laws, the regulations of Communist party and traditional "moral" values).The religion, the definition of "success", "integrity" and "kindness" could be unique.For example, in order to free the psychological and economic burdens of family, some patients with complex diseases, such as cancer, neurodegenerative diseases, even
Author: Yue Zhang
Language: English
Subfield: Physiology
Field: Medicine
Open Access status: diamond
OpenAlex ID: W2770198970
FWCI:
Cites: 3
Cited by:
Related to: 10